This department is offering the CBMS-BAA-07-01 grant to support the development of medical Chemical, Biological, Radiological, and Nuclear (CBRN) countermeasures. The grant aims to solicit pre-proposals for the development of prototypes and areas not related to specific system or hardware procurement. Eligible sources include educational institutions, nonprofit organizations, and private industry. Proposals can be continuously submitted and will be evaluated throughout the year. The announcement highlights specific project areas, areas of interest, evaluation criteria, and proposal preparation instructions. Communication and inquiries related to the grant can be directed to the provided email address. The closing date for applications is March 31, 2011.
Opportunity ID: 45060
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 11 |
| Posted Date: | Jan 29, 2009 |
| Last Updated Date: | Jul 19, 2011 |
| Original Closing Date for Applications: | Aug 30, 2009 |
| Current Closing Date for Applications: | Mar 31, 2011 |
| Archive Date: | Apr 30, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. URL has been updated. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Revisions to the General Information and Proposal Preparation and Areas of Interest Documents. | Jul 19, 2011 | |
| Extend expiration date to 31 Mar 2011 | Jul 19, 2011 | |
| Extend expiration date to 31 Mar 2011 | Jan 04, 2011 | |
| Extend expiration date to 31 Mar 10 | Jan 04, 2011 | |
| Extend closing date to 31 Dec 2010 | Jan 04, 2011 | |
| Extend closing date | Nov 03, 2010 | |
| The purpose of this modification is to extend the closing date. | Nov 03, 2010 | |
| URL has been updated | Aug 10, 2010 | |
| Extension of closing date to 31 August 2010. | Mar 26, 2010 | |
| Extension of closing date to 31 August 2010. | Aug 28, 2009 | |
| Aug 28, 2009 |
DISPLAYING: Synopsis 11
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 11 |
| Posted Date: | Jan 29, 2009 |
| Last Updated Date: | Jul 19, 2011 |
| Original Closing Date for Applications: | Aug 30, 2009 |
| Current Closing Date for Applications: | Mar 31, 2011 |
| Archive Date: | Apr 30, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. URL has been updated. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
DISPLAYING: Synopsis 10
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 10 |
| Posted Date: | Jul 19, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 31, 2011 |
| Archive Date: | Apr 30, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. URL has been updated. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
DISPLAYING: Synopsis 9
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 9 |
| Posted Date: | Jan 04, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 31, 2011 |
| Archive Date: | Apr 30, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. URL has been updated. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
DISPLAYING: Synopsis 8
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 8 |
| Posted Date: | Jan 04, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Dec 31, 2010 |
| Archive Date: | Jan 30, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. URL has been updated. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
DISPLAYING: Synopsis 7
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 7 |
| Posted Date: | Jan 04, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Dec 31, 2010 |
| Archive Date: | Jan 30, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. URL has been updated. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
DISPLAYING: Synopsis 6
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 6 |
| Posted Date: | Nov 03, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Oct 31, 2010 |
| Archive Date: | Nov 30, 2010 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. URL has been updated. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
DISPLAYING: Synopsis 5
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | Nov 03, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Oct 31, 2010 |
| Archive Date: | Nov 30, 2010 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. URL has been updated. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Aug 10, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Aug 31, 2010 |
| Archive Date: | Sep 29, 2010 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. URL has been updated. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Mar 26, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Aug 31, 2010 |
| Archive Date: | Sep 29, 2010 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Aug 28, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Aug 30, 2009 |
| Archive Date: | Sep 29, 2009 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CBMS-BAA-07-01 |
| Funding Opportunity Title: | CBMS-BAA-07-01 |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 100 |
| Assistance Listings: | 12.360 — Research on Chemical and Biological Defense |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 28, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Aug 30, 2009 |
| Archive Date: | Sep 29, 2009 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — Space & Missle Defense Comman |
| Description: | Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the Areas of Interest attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMOs project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the Areas of Interest. This announcement of the U.S. Governments current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to cbmsbaa@amedd.army.mil.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to cbmsbaa@amedd.army.mil, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email support@grants.gov. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sandra O’Connell
Contract Specialist/Grants Officer Phone 301-619-2895 Email:sandra.oconnell@us.army.mil |
Related Documents
Folder 45060 Full Announcement-1 -> cbms baa 07-01areas of interest jul 11.pdf
Folder 45060 Full Announcement-1 -> cbms baa 07-01general information and proposal preparation jul 11.pdf
Folder 45060 Full Announcement-1 -> cbms baatrls 09.pdf
Packages
| Agency Contact Information: | Sandra O’Connell Contract Specialist/Grants Officer Phone 301-619-2895 Email: sandra.oconnell@us.army.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.360 | PKG00010256 | Dec 31, 2010 | View |
Package 1
Mandatory forms
45060 RR_SF424-1.1.pdf
45060 RR_Budget-1.1.pdf
45060 RR_OtherProjectInfo-1.1.pdf
Optional forms
45060 RR_SubawardBudget-1.2.pdf
45060 RR_PerformanceSite-1.1.pdf
45060 RR_FedNonFed_SubawardBudget-1.2.pdf
Leave a Reply